1. Home
  2. SOL vs SLS Comparison

SOL vs SLS Comparison

Compare SOL & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOL
  • SLS
  • Stock Information
  • Founded
  • SOL 2005
  • SLS 2012
  • Country
  • SOL United States
  • SLS United States
  • Employees
  • SOL N/A
  • SLS N/A
  • Industry
  • SOL Semiconductors
  • SLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOL Technology
  • SLS Health Care
  • Exchange
  • SOL Nasdaq
  • SLS Nasdaq
  • Market Cap
  • SOL 84.6M
  • SLS 89.6M
  • IPO Year
  • SOL 2008
  • SLS N/A
  • Fundamental
  • Price
  • SOL $1.48
  • SLS $1.56
  • Analyst Decision
  • SOL Buy
  • SLS
  • Analyst Count
  • SOL 3
  • SLS 0
  • Target Price
  • SOL $3.50
  • SLS N/A
  • AVG Volume (30 Days)
  • SOL 162.2K
  • SLS 2.0M
  • Earning Date
  • SOL 05-22-2025
  • SLS 05-20-2025
  • Dividend Yield
  • SOL N/A
  • SLS N/A
  • EPS Growth
  • SOL N/A
  • SLS N/A
  • EPS
  • SOL N/A
  • SLS N/A
  • Revenue
  • SOL $92,067,000.00
  • SLS N/A
  • Revenue This Year
  • SOL N/A
  • SLS N/A
  • Revenue Next Year
  • SOL $45.37
  • SLS N/A
  • P/E Ratio
  • SOL N/A
  • SLS N/A
  • Revenue Growth
  • SOL N/A
  • SLS N/A
  • 52 Week Low
  • SOL $1.04
  • SLS $0.77
  • 52 Week High
  • SOL $3.00
  • SLS $1.85
  • Technical
  • Relative Strength Index (RSI)
  • SOL 56.58
  • SLS 61.26
  • Support Level
  • SOL $1.25
  • SLS $1.60
  • Resistance Level
  • SOL $1.40
  • SLS $1.85
  • Average True Range (ATR)
  • SOL 0.07
  • SLS 0.13
  • MACD
  • SOL 0.03
  • SLS 0.02
  • Stochastic Oscillator
  • SOL 79.39
  • SLS 50.85

About SOL Emeren Group Ltd each representing 10 shares

Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: